Pharmacokinetic and bioequivalence study of two gemfibrozil preparations

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 8, 1997, Pages 913-916

  Benkö, Sarolta ^a   Drabant, Sándor ^a   Grézal, Gyula ^a   Ürmös, Iván ^a   Csörgö, Margit ^a   Klebovich, Imre ^a  

^a EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Antihyperlipaemic drug; Bioequivalence; CAS 25812 30 0; Clinical studies; Gemfibrozil; Innogem ; Pharmacokinetics

Indexed keywords

GEMFIBROZIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISSOLUTION; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADULT; ANTILIPEMIC AGENTS; AREA UNDER CURVE; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOUBLE-BLIND METHOD; GEMFIBROZIL; HALF-LIFE; HUMANS; MALE; SPECTROPHOTOMETRY, ULTRAVIOLET; THERAPEUTIC EQUIVALENCY;

EID: 0030875048     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nash, D. T., J. Med. 11, 107 (1980)
2. Rodney, G., Uhlendorf, P., Maxwell, R. E., Proc. R. Soc. Med. 69 (Suppl 2), 6 (1976)
3. Kisselbach, A. H., Adams, P. A., Wynn, V., Proc. R. Soc. Med. 69 (Suppl 2), 94 (1976)
4. Todd, P. A., Ward, A., Drugs 36, 314 (1988)
5. Leiss, O., von Bergmann et al., Metabolism 34, 74 (1985)
6. Saku, K., Hynd, B. A. et al., Arteriosclerosis 3, 484a (1983)
7. Smith, T. C., Proc. R. Soc. Med. 69 (Suppl 2), 24 (1976)
8. Knauf, H., Kölle, E. U., Mutschler, E., Klin. Wochenschr. 68, 692 (1990)
9. Hamberger, C., Barre, J. et al., Int. J. Clin. Pharm. Res. 6, 441 (1986)
10. Okerholm, R. A., Keeley, F. I., Peterson, F. E. et al., Proc. R. Soc. Med. 69 (Suppl 2), 11 (1976)
11. Hodges, R. M., Marcus, E. I., Res. Clin. Forums 4, 37 (1982)
12. Hengy, H., Kölle, E. U., Arzneim.-Forsch./Drug Res. 35 (II), 1637 (1985)
13. Pabst, G., Jaeger, H., Eur. J. Clin. Pharmacol. 38, 5 (1990)
14. Westlake, W. J., Biometrics 32, 741 (1976)
15. Spriet, A., Beiler, D., Eur. J. Drug Metab. Pharmacokinet. 3, 129 (1978)
16. Westlake, W. J., Biometrics 35, 273 (1979)
17. Schuirmann, J. D., J. Pharmacokinet. Biopharm. 15, 657 (1987)
18. Hauck, W. W., Anderson, S. J., Pharmacokinet. Biopharm. 12, 83 (1984)
19. Comission of the European Communities: Guidance for investigation of bioavailability and bioequivalence (Appendix III. Technical aspects of bioequivalence statistics), Brussels, III/54/1. 5. 1992 -
20. Tallarida, R. J., Murray, R. B., Manual of Pharmacological Calculations, Springer-Verlag, New York (1986)
21. Shah, U. P., Midha, K. K., Dighe, S. et al., Pharm. Res. 9, 588 (1992)